Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Curiosity Weekly

Shark Hunter, Asbestos Cancer Treatment, Creative Flow

03 Apr 2024

Description

Today, you’ll learn about an alarming new killer behavior in orcas, a potential breakthrough for patients with one of the deadliest cancers, and the brain science behind flow.   Shark Hunter  “Orcas Demonstrating They No Longer Need to Hunt in Packs to Take Down the Great White Shark.” Taylor & Francis. 2024.  “Further insights into killer whales Orcinus orca preying on white sharks Carcharodon carcharias in South Africa.” by A Towner, et al. 2024.  “Top 10 Facts About Orcas.” WWF. 2023.  Asbestos Cancer Treatment  “Drug offers ‘wonderful’ breakthrough in treatment of asbestos-linked cancer.” by Andrew Gregory. 2024.  “Key Statistics About Malignant Mesothelioma.” American Cancer Society. 2019. “Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma.” by Peter W. Szlosarek, MD, PhD. et al. 2024.  Creative Flow  “Your brain in the zone: A new neuroimaging study reveals how the brain achieves a creative flow state.” EurekAlert! 2024.  “Creative flow as optimized processing: Evidence from brain oscillations during jazz improvisations by expert and non-expert musicians.” by David Rosen, et al. 2024.   Follow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers.  Hosted on Acast. See acast.com/privacy for more information.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.